Team Approach to Polypharmacy Evaluation and Reduction for General Practice patients with dementia: the Australian TAPERdem study.

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/GNT1139616

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Dementia frequently coexists with other chronic conditions, posing a challenge to optimise medication use. Suboptimal pharmacological management of comorbidities exacerbates the rate of functional decline of PWD. The present study will determine to what extent improved medication management produces better health and functional outcomes for PWD.

Funded Activity Details

Start Date: 01-01-2018

End Date: 01-01-2021

Funding Scheme: Targeted Calls

Funding Amount: $586,840.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Clinical Pharmacology and Therapeutics

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

comorbidity | dementia care | medications | pharmacology | pharmacy

Related Links